Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple relaxation methods show promise for PMS relief

NCT ID NCT07526623

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether combining two relaxation techniques—Benson relaxation and Jacobson progressive muscle relaxation—can reduce symptoms of premenstrual syndrome (PMS) in women aged 18 to 30. Fifty-six female students with PMS will be split into three groups: one using Benson relaxation, one using Jacobson relaxation, and one using both techniques together. They will practice these methods three times a week for two months, and their symptoms will be measured before and after the treatment using a standard PMS scale.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

56 people

The number who actually took part.

Started

Apr 2026

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 30 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between (18-30 years) * suffering from PMS * score of 45 or greater on PMSS * having regular menstrual cycle between 21- 35 days * not having a diagnosis of psychiatric problems * Not having gynecologic disease like abnormal uterine bleeding, ovarian cysts, uterine, fibroids etc. * Not having any health problem or underlying disease that prevent PMRT. Exclusion Criteria: * Not using contraceptive pills * Not attending sessions * To reduce PMS use another methods * Withdrawing from the study voluntarily at any stage after inclusion * Anemia, chronic health conditions, communication related disability * Any current pharmacologic or non-pharmacologic treatment of PMS

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Premenstrual syndrome-PMS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Health Sciences Lahore

    Lahore, Punjab Province, 54000g, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.